{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:43:28Z","timestamp":1793472208267,"version":"4.5.0"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuint.2025.106070","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:37:18Z","timestamp":1759937838000},"page":"106070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Crossing the Borders: the amino acid transporter LAT1 (SLC7A5) in the Blood-Brain Barrier"],"prefix":"10.1016","volume":"191","author":[{"given":"Mariafrancesca","family":"Scalise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Scanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Console","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Galluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviana","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Magr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Pochini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9818-6621","authenticated-orcid":false,"given":"Cesare","family":"Indiveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2025.106070_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2025.106070_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jcb.23022","article-title":"CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines","volume":"112","author":"Abdelmagid","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neuint.2025.106070_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy137","article-title":"LAT1-like transporters regulate dopaminergic transmission and sleep in drosophila","volume":"41","author":"Aboudhiaf","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/j.neuint.2025.106070_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105771","article-title":"Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives","volume":"177","author":"Adla","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2025.106070_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio.1002","article-title":"Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria","volume":"8","author":"Adler-Abramovich","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuint.2025.106070_bib6","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1007\/s12035-024-04506-9","article-title":"The multifaceted role of L-Type amino acid transporter 1 at the blood-brain barrier: structural implications and therapeutic potential","volume":"62","author":"Ahmed","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2025.106070_bib7","first-page":"633","article-title":"Pericyte morphology and function","volume":"36","author":"Alarcon-Martinez","year":"2021","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neuint.2025.106070_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-022-01091-5","article-title":"The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders","volume":"38","author":"Alijanpour","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuint.2025.106070_bib9","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-20-2870","article-title":"GLUT1 expression in tumor-associated neutrophils promotes lung cancer growth and resistance to radiotherapy","volume":"81","author":"Ancey","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuint.2025.106070_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/0118715273329531240911075309","article-title":"Revolutionising neurological therapeutics: investigating drug repurposing strategies","volume":"24","author":"Attri","year":"2025","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.neuint.2025.106070_bib11","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.bmcl.2016.04.023","article-title":"LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs","volume":"26","author":"Augustyn","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuint.2025.106070_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/acs.molpharmaceut.2c00594","article-title":"Structural features affecting the interactions and transportability of LAT1-Targeted phenylalanine drug conjugates","volume":"20","author":"Bahrami","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53065-w","article-title":"Ubiquitylation and endocytosis of the human LAT1\/SLC7A5 amino acid transporter","volume":"9","author":"Barthelemy","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106070_bib14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/1381612043384844","article-title":"ABC transporters and the blood-brain barrier","volume":"10","author":"Begley","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuint.2025.106070_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.chembiol.2020.04.003","article-title":"Targeted degradation of SLC transporters reveals amenability of multi-pass transmembrane proteins to ligand-induced proteolysis","volume":"27","author":"Bensimon","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.neuint.2025.106070_bib16","article-title":"The rs113883650 variant of SLC7A5 (LAT1) gene May alter brain phenylalanine content in PKU","volume":"27","author":"Bik-Multanowski","year":"2021","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.neuint.2025.106070_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbamem.2005.07.007","article-title":"Site-directed mutagenesis of cysteine residues of large neutral amino acid transporter LAT1","volume":"1715","author":"Boado","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2025.106070_bib18","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","article-title":"Selective expression of the large neutral amino acid transporter at the blood-brain barrier","volume":"96","author":"Boado","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2025.106070_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.canlet.2014.09.025","article-title":"Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy","volume":"356","author":"Brenner","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuint.2025.106070_bib20","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1042\/BCJ20160822","article-title":"Amino acid homeostasis and signalling in Mammalian cells and organisms","volume":"474","author":"Broer","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2025.106070_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22064","article-title":"Structure and allosteric inhibition of excitatory amino acid transporter 1","volume":"544","author":"Canul-Tec","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106070_bib22","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1038\/s41598-024-55252-w","article-title":"Structure-activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106070_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103880","article-title":"Design strategies and recent development of bioactive modulators for glutamine transporters","volume":"29","author":"Cheng","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuint.2025.106070_bib24","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/humu.24089","article-title":"Functional consequences of SLC1A3 mutations associated with episodic ataxia 6","volume":"41","author":"Chivukula","year":"2020","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuint.2025.106070_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13195-024-01623-4","article-title":"Alzheimer's disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway","volume":"16","author":"Choe","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuint.2025.106070_bib26","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1158\/1078-0432.CCR-05-0722","article-title":"Food and drug administration drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme","volume":"11","author":"Cohen","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuint.2025.106070_bib27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41594-018-0026-8","article-title":"Structural basis for recognition of diverse antidepressants by the human serotonin transporter","volume":"25","author":"Coleman","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuint.2025.106070_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature17629","article-title":"X-ray structures and mechanism of the human serotonin transporter","volume":"532","author":"Coleman","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106070_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18779-4","article-title":"N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98)","volume":"12","author":"Console","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106070_bib30","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1158\/0008-5472.CAN-15-3376","article-title":"Genetic disruption of the multifunctional CD98\/LAT1 complex demonstrates the key role of essential amino acid transport in the control of mTORC1 and tumor growth","volume":"76","author":"Cormerais","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuint.2025.106070_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73757-y","article-title":"ATP modulates SLC7A5 (LAT1) synergistically with cholesterol","volume":"10","author":"Cosco","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106070_bib32","doi-asserted-by":"crossref","first-page":"60962","DOI":"10.18632\/oncotarget.17631","article-title":"Hepatitis B virus X protein-induced upregulation of CAT-1 stimulates proliferation and inhibits apoptosis in hepatocellular carcinoma cells","volume":"8","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuint.2025.106070_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/a-1290-0119","article-title":"Design, synthesis and enhanced BBB penetration studies of L-serine-Tethered nipecotic acid-prodrug","volume":"71","author":"Dhanawat","year":"2021","journal-title":"Drug Res."},{"key":"10.1016\/j.neuint.2025.106070_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/srep43580","article-title":"Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol","volume":"7","author":"Dickens","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106070_bib35","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1016\/j.cell.2025.02.034","article-title":"Cell membranes sustain phospholipid imbalance via cholesterol asymmetry","volume":"188","author":"Doktorova","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2025.106070_bib36","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1006\/jmcc.1999.0965","article-title":"Myocardial glucose transporter GLUT1: translocation induced by insulin and ischemia","volume":"31","author":"Egert","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.neuint.2025.106070_bib37","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41467-019-09837-z","article-title":"L amino acid transporter structure and molecular bases for the asymmetry of substrate interaction","volume":"10","author":"Errasti-Murugarren","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106070_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","article-title":"The SLC3 and SLC7 families of amino acid transporters","volume":"34","author":"Fotiadis","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuint.2025.106070_bib39","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/endo.142.10.8418","article-title":"Thyroid hormone transport by the heterodimeric human system L amino acid transporter","volume":"142","author":"Friesema","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuint.2025.106070_bib40","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00424-014-1596-x","article-title":"Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS","volume":"467","author":"Gao","year":"2015","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuint.2025.106070_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.963066","article-title":"Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells","volume":"13","author":"Gauthier-Coles","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib42","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1073\/pnas.1218165110","article-title":"Structure-based ligand discovery for the large-neutral amino acid Transporter 1, LAT-1","volume":"110","author":"Geier","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2025.106070_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2018.08.011","article-title":"L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles","volume":"15","author":"Gonzalez-Carter","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.neuint.2025.106070_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbpa.2021.07.005","article-title":"Metabolite assemblies: a surprising extension to the amyloid hypothesis","volume":"64","author":"Gour","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuint.2025.106070_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041707","article-title":"Amino acid transporter LAT1 (SLC7A5) mediates MeHg-Induced oxidative stress defense in the human placental cell line HTR-8\/SVneo","volume":"22","author":"Granitzer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib46","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00204-020-02826-y","article-title":"Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants","volume":"94","author":"Gutbier","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuint.2025.106070_bib47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2010.08.019","article-title":"Brain uptake of ketoprofen-lysine prodrug in rats","volume":"399","author":"Gynther","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib48","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1021\/jm701175d","article-title":"Large neutral amino acid transporter enables brain drug delivery via prodrugs","volume":"51","author":"Gynther","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2025.106070_bib49","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s11064-016-1996-8","article-title":"Amino acid promoieties alter valproic acid pharmacokinetics and enable extended brain exposure","volume":"41","author":"Gynther","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2025.106070_bib50","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/acs.molpharmaceut.6b00217","article-title":"Systemic and brain pharmacokinetics of perforin inhibitor prodrugs","volume":"13","author":"Gynther","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11095-018-2546-7","article-title":"Alzheimer's Disease phenotype or inflammatory insult does not alter function of L-Type amino acid transporter 1 in mouse blood-brain barrier and primary astrocytes","volume":"36","author":"Gynther","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuint.2025.106070_bib52","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.bmcl.2019.06.033","article-title":"l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan","volume":"29","author":"Hall","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuint.2025.106070_bib53","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/jps.23575","article-title":"Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset","volume":"102","author":"Hoshi","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1034964","article-title":"Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain","volume":"13","author":"Hugele","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib55","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1021\/acs.jctc.3c01391","article-title":"Comprehensive characterization of LAT1 cholesterol-binding sites","volume":"20","author":"Hutchinson","year":"2024","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.neuint.2025.106070_bib56","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1016\/j.bpj.2022.11.001","article-title":"Describing inhibitor specificity for the amino acid transporter LAT1 from metainference simulations","volume":"121","author":"Hutchinson","year":"2022","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuint.2025.106070_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061234","article-title":"Increased\/Targeted brain (Pro)Drug delivery via utilization of solute carriers (SLCs)","volume":"14","author":"Huttunen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuint.2025.106070_bib58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijpharm.2018.08.047","article-title":"Targeted efflux transporter inhibitors - a solution to improve poor cellular accumulation of anti-cancer agents","volume":"550","author":"Huttunen","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49009-z","article-title":"L-Type amino acid transporter 1 (LAT1\/Lat1)-Utilizing prodrugs can improve the delivery of drugs into neurons, astrocytes and Microglia","volume":"9","author":"Huttunen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106070_bib60","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/17425247.2024.2355180","article-title":"Improving drug delivery to the brain: the prodrug approach","volume":"21","author":"Huttunen","year":"2024","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.neuint.2025.106070_bib61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2015.12.034","article-title":"L-Type amino acid transporter 1 (lat1)-mediated targeted delivery of perforin inhibitors","volume":"498","author":"Huttunen","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib62","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1073\/pnas.1605442113","article-title":"Insights into the molecular basis for substrate binding and specificity of the wild-type L-arginine\/agmatine antiporter AdiC","volume":"113","author":"Ilgu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2025.106070_bib63","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.cellsig.2014.04.002","article-title":"Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration","volume":"26","author":"Janpipatkul","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuint.2025.106070_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106637","article-title":"Altering distribution profile of palbociclib by its prodrugs","volume":"192","author":"Jarvinen","year":"2024","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib65","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41467-018-03066-6","article-title":"Structural basis for amino acid transport by the CAT family of SLC7 transporters","volume":"9","author":"Jungnickel","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106070_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neuint.2025.106070_bib67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","article-title":"The 4F2hc\/LAT1 complex transports L-DOPA across the blood-brain barrier","volume":"879","author":"Kageyama","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2025.106070_bib68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/IGC.0b013e3181d28e13","article-title":"Properties of L-type amino acid transporter 1 in epidermal ovarian cancer","volume":"20","author":"Kaji","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.neuint.2025.106070_bib69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mam.2013.01.001","article-title":"The SLC1 high-affinity glutamate and neutral amino acid transporter family","volume":"34","author":"Kanai","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuint.2025.106070_bib70","doi-asserted-by":"crossref","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","article-title":"Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)","volume":"273","author":"Kanai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106070_bib71","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","article-title":"Amino acid transporters revisited: new views in health and disease","volume":"43","author":"Kandasamy","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207573","article-title":"The heavy chain 4F2hc modulates the substrate affinity and specificity of the light chains LAT1 and LAT2","volume":"21","author":"Kantipudi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib73","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1073\/pnas.1722677115","article-title":"ASCT1 (Slc1a4) transporter is a physiologic regulator of brain d-serine and neurodevelopment","volume":"115","author":"Kaplan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2025.106070_bib74","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1248\/bpb.31.1096","article-title":"BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells","volume":"31","author":"Kim","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuint.2025.106070_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70044","article-title":"Glut1 deficiency syndrome: novel pathomechanisms, Current concepts, and challenges","volume":"48","author":"Klepper","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuint.2025.106070_bib76","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.cell.2023.02.037","article-title":"Large neutral amino acid levels tune perinatal neuronal excitability and survival","volume":"186","author":"Knaus","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2025.106070_bib77","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuint.2025.106070_bib78","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jphs.2017.01.006","article-title":"Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)","volume":"133","author":"Kongpracha","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib79","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fphar.2018.00027","article-title":"Transporter-Guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types","volume":"9","author":"Kou","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib80","article-title":"Targeting the kynurenine pathway in gliomas: insights into pathogenesis, therapeutic targets, and clinical advances","volume":"1880","author":"Krupa","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.neuint.2025.106070_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114265","article-title":"Investigating sleep spindle density and schizophrenia: a meta-analysis","volume":"307","author":"Lai","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuint.2025.106070_bib82","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41467-025-56903-w","article-title":"Structural basis of anticancer drug recognition and amino acid transport by LAT1","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106070_bib83","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41594-019-0237-7","article-title":"Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc","volume":"26","author":"Lee","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuint.2025.106070_bib84","doi-asserted-by":"crossref","first-page":"20102","DOI":"10.1074\/jbc.M413164200","article-title":"Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106070_bib85","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00259-024-06600-5","article-title":"A bis-boron boramino acid PET tracer for brain tumor diagnosis","volume":"51","author":"Li","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.neuint.2025.106070_bib86","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s11845-021-02675-3","article-title":"Expression and clinical significance of organic cation transporter family in glioblastoma multiforme","volume":"191","author":"Lian","year":"2022","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10495-020-01603-7","article-title":"Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis","volume":"25","author":"Markowicz-Piasecka","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuint.2025.106070_bib88","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/ijc.30371","article-title":"LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma","volume":"139","author":"Marshall","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neuint.2025.106070_bib89","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/26246","article-title":"Amino-acid transport by heterodimers of 4F2hc\/CD98 and members of a permease family","volume":"395","author":"Mastroberardino","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106070_bib90","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1016\/j.bmcl.2010.04.086","article-title":"Regiospecific and conformationally restrained analogs of melphalan and DL-2-NAM-7 and their affinities for the large neutral amino acid transporter (system LAT1) of the blood-brain barrier","volume":"20","author":"Matharu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuint.2025.106070_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116565","article-title":"Carnitine traffic and human fertility","volume":"230","author":"Mazza","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib92","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbr.2018.12.023","article-title":"Upregulation of the lactate transporter monocarboxylate transporter 1 at the blood-brain barrier in a rat model of attention-deficit\/hyperactivity disorder suggests hyperactivity could be a form of self-treatment","volume":"360","author":"Medin","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2025.106070_bib93","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<90::AID-MUS12>3.0.CO;2-M","article-title":"Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport","volume":"23","author":"Merezhinskaya","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuint.2025.106070_bib94","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1038\/ncomms8250","article-title":"LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation","volume":"6","author":"Milkereit","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106070_bib95","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.radonc.2016.08.014","article-title":"Prognostic value of (18)F-FET PET imaging in re-irradiation of high-grade glioma: results of a phase I clinical trial","volume":"121","author":"Moller","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.neuint.2025.106070_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3528148","article-title":"Astrocyte-Targeted transporter-utilizing derivatives of ferulic acid can have multifunctional effects ameliorating inflammation and oxidative stress in the brain","volume":"2019","author":"Montaser","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuint.2025.106070_bib97","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1021\/acschemneuro.0c00564","article-title":"L-Type amino acid transporter 1 enables the efficient brain delivery of small-sized prodrug across the blood-brain barrier and into human and Mouse brain parenchymal cells","volume":"11","author":"Montaser","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2025.106070_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121088","article-title":"Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice","volume":"310","author":"Montaser","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib99","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.neuint.2025.106070_bib100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cbpa.2018.05.011","article-title":"Beyond cysteine: recent developments in the area of targeted covalent inhibition","volume":"44","author":"Mukherjee","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuint.2025.106070_bib101","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1039\/D3TB90089D","article-title":"Correction: blood brain barrier permeable gold nanocluster for targeted brain imaging and therapy: an in vitro and in vivo study","volume":"11","author":"Nair","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.neuint.2025.106070_bib102","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbagen.2017.01.013","article-title":"Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation","volume":"1861","author":"Napolitano","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.neuint.2025.106070_bib103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biocel.2015.08.004","article-title":"LAT1 is the transport competent unit of the LAT1\/CD98 heterodimeric amino acid transporter","volume":"67","author":"Napolitano","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuint.2025.106070_bib104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcp.2017.07.006","article-title":"Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs","volume":"143","author":"Napolitano","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41581-019-0111-1","article-title":"Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling","volume":"15","author":"Nigam","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.neuint.2025.106070_bib106","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1349-7006.2009.01386.x","article-title":"L-type amino acid transporter 1 inhibitors inhibit tumor cell growth","volume":"101","author":"Oda","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib107","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10637-020-00924-3","article-title":"First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors","volume":"38","author":"Okano","year":"2020","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.neuint.2025.106070_bib108","article-title":"A novel blood-brain barrier-permeable chemotherapeutic agent for the treatment of glioblastoma","volume":"13","author":"Ozawa","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.neuint.2025.106070_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27206984","article-title":"Nipecotic acid derivatives as potent agents against neurodegeneration: a preliminary Study","volume":"27","author":"Papagiouvannis","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuint.2025.106070_bib110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ijnp\/pyaa025","article-title":"A randomized trial of the N-Methyl-d-Aspartate receptor glycine site antagonist prodrug 4-Chlorokynurenine in treatment-resistant depression","volume":"23","author":"Park","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib111","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/acs.molpharmaceut.0c00727","article-title":"Probenecid increases the concentration of 7-Chlorokynurenic acid derived from the prodrug 4-Chlorokynurenine within the prefrontal cortex","volume":"18","author":"Patel","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature12533","article-title":"X-ray structure of dopamine transporter elucidates antidepressant mechanism","volume":"503","author":"Penmatsa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106070_bib113","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12929-025-01158-2","article-title":"Guilty by association: direct interaction with the tetraspanin CD63 suggests a role for organic cation transporter 3 in histamine release from granulocytes","volume":"32","author":"Pernecker","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib114","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s11095-012-0966-3","article-title":"Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine","volume":"30","author":"Peura","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuint.2025.106070_bib115","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/mp2001878","article-title":"Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery","volume":"8","author":"Peura","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062132","article-title":"Tyrosine-Chlorambucil conjugates facilitate cellular uptake through L-Type amino acid transporter 1 (LAT1) in human breast cancer cell line MCF-7","volume":"21","author":"Pocasap","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib117","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2472555218812821","article-title":"OCTN: a small transporter subfamily with great relevance to human pathophysiology, drug discovery, and diagnostics","volume":"24","author":"Pochini","year":"2019","journal-title":"SLAS Discov"},{"key":"10.1016\/j.neuint.2025.106070_bib118","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-022-03241-x","article-title":"Targeting transporters for drug delivery to the brain: can we Do better?","volume":"39","author":"Puris","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuint.2025.106070_bib119","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11095-020-02826-8","article-title":"L-Type amino acid transporter 1 as a target for drug delivery","volume":"37","author":"Puris","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuint.2025.106070_bib120","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acs.molpharmaceut.9b00502","article-title":"Mechanistic Study on the use of the l-Type amino acid transporter 1 for brain intracellular delivery of Ketoprofen via prodrug: a novel approach supporting the development of prodrugs for intracellular targets","volume":"16","author":"Puris","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib121","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2017.06.023","article-title":"L-type amino acid transporter 1 utilizing prodrugs: how to achieve effective brain delivery and low systemic exposure of drugs","volume":"261","author":"Puris","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.neuint.2025.106070_bib122","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1042\/bj3560719","article-title":"Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta","volume":"356","author":"Ritchie","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2025.106070_bib123","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1038\/s41467-025-60304-4","article-title":"Loss of CD98HC phosphorylation by ATM impairs antiporter trafficking and drives glutamate toxicity in Ataxia telangiectasia","volume":"16","author":"Romero","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106070_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.neuint.2025.106070_bib125","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1074\/jbc.270.25.14913","article-title":"Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier","volume":"270","author":"Sanchez del Pino","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106070_bib126","series-title":"GeneReviews((R))","article-title":"Allan-Herndon-Dudley syndrome","author":"Sarret","year":"1993"},{"key":"10.1016\/j.neuint.2025.106070_bib127","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1126\/science.aad2087","article-title":"Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway","volume":"351","author":"Saxton","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neuint.2025.106070_bib128","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1177\/24725552211030288","article-title":"ASCT1 and ASCT2: brother and sister?","volume":"26","author":"Scalise","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.neuint.2025.106070_bib129","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/2472555219856601","article-title":"Exploiting cysteine residues of SLC membrane transporters as targets for drugs","volume":"24","author":"Scalise","year":"2019","journal-title":"SLAS Discov"},{"key":"10.1016\/j.neuint.2025.106070_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152277","article-title":"The antiport mechanism of the human LAT1 transporter: defining the molecular determinants by means of wet and dry approaches","volume":"777","author":"Scalise","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2025.106070_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbabio.2024.149520","article-title":"Lysine 204 is crucial for the antiport function of the human LAT1 transporter","volume":"1866","author":"Scalise","year":"2025","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.neuint.2025.106070_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107738","article-title":"LAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism","volume":"26","author":"Scanga","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.neuint.2025.106070_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.877576","article-title":"The nutraceutical alliin from garlic is a novel substrate of the essential amino acid transporter LAT1 (SLC7A5)","volume":"13","author":"Scanga","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117075","article-title":"Impact of 7-ketocholesterol on the function and stability of the LAT1 transporter","author":"Scanga","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib135","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","article-title":"Targeting SLC transporters: small molecules as modulators and therapeutic opportunities","volume":"48","author":"Schlessinger","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib136","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1080\/21691401.2016.1276919","article-title":"Development and characterization of morin hydrate loaded microemulsion for the management of Alzheimer's disease","volume":"45","author":"Sharma","year":"2017","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.neuint.2025.106070_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115258","article-title":"Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases","volume":"251","author":"Shen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuint.2025.106070_bib138","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001756-200403220-00001","article-title":"Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas","volume":"15","author":"Sidoryk","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2025.106070_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051278","article-title":"Insights into the structure, function, and ligand discovery of the large neutral amino acid transporter 1, LAT1","volume":"19","author":"Singh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-201556","article-title":"Copper imbalance in Alzheimer's Disease and its link with the amyloid Hypothesis: towards a combined clinical, chemical, and genetic etiology","volume":"83","author":"Squitti","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuint.2025.106070_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158446","article-title":"Development of Sesamol Carbamate-L-Phenylalanine prodrug targeting L-Type amino acid Transporter 1 (LAT1) as a potential antiproliferative agent against Melanoma","volume":"23","author":"Srisongkram","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib142","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tox.2015.12.005","article-title":"Mercury toxicokinetics of the healthy human term placenta involve amino acid transporters and ABC transporters","volume":"340","author":"Straka","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.neuint.2025.106070_bib143","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuint.2025.106070_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108588","article-title":"Modifications of physical and functional integrity of the blood-brain barrier in an inducible mouse model of neurodegeneration","volume":"191","author":"Taccola","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2025.106070_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/cells12202504","article-title":"L-Type amino acid transporter 1 (LAT1) promotes PMA-Induced cell migration through mTORC2 activation at the lysosome","volume":"12","author":"Tae","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2025.106070_bib146","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s12035-020-02045-7","article-title":"Targeting of perforin inhibitor into the brain parenchyma via a prodrug approach can decrease oxidative stress and neuroinflammation and improve cell survival","volume":"57","author":"Tampio","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2025.106070_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120565","article-title":"Improved l-Type amino acid transporter 1 (LAT1)-mediated delivery of anti-inflammatory drugs into astrocytes and microglia with reduced prostaglandin production","volume":"601","author":"Tampio","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109560","article-title":"Hemocompatible L-Type amino acid transporter 1 (LAT1)-Utilizing prodrugs of perforin inhibitors can accumulate into the pancreas and alleviate inflammation-induced apoptosis","volume":"345","author":"Tampio","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuint.2025.106070_bib149","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1021\/acs.molpharmaceut.2c00328","article-title":"L-type amino acid transporter 1 utilizing ferulic acid derivatives show increased drug delivery in the mouse pancreas along with decreased lipid peroxidation and prostaglandin production","volume":"19","author":"Tampio","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuint.2025.106070_bib150","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","article-title":"Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder","volume":"167","author":"Tarlungeanu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2025.106070_bib151","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fphys.2018.00171","article-title":"Functional polarity of Microvascular brain endothelial cells supported by neurovascular unit computational model of large neutral amino acid homeostasis","volume":"9","author":"Taslimifar","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuint.2025.106070_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000385","article-title":"Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons","volume":"2","author":"Taubert","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2025.106070_bib153","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.bmcl.2018.07.030","article-title":"Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrug","volume":"28","author":"Thiele","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuint.2025.106070_bib154","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2025.106070_bib155","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0026-895X(24)12322-X","article-title":"Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition","volume":"61","author":"Uchino","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib156","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/cas.13908","article-title":"Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes","volume":"110","author":"Ueda","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib157","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1056\/NEJMoa1407778","article-title":"Monocarboxylate transporter 1 deficiency and ketone utilization","volume":"371","author":"van Hasselt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2025.106070_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112572","article-title":"Untreated PKU patients without intellectual disability: what do they teach Us?","volume":"11","author":"van Vliet","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.neuint.2025.106070_bib159","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00424-003-1086-z","article-title":"CATs and HATs: the SLC7 family of amino acid transporters","volume":"447","author":"Verrey","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuint.2025.106070_bib160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10545-012-9524-8","article-title":"Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice","volume":"36","author":"Vogel","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuint.2025.106070_bib161","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41380-018-0076-7","article-title":"Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice","volume":"24","author":"Walker","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuint.2025.106070_bib162","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-025-07617-w","article-title":"Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1alpha\/HIF2alpha regulation","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuint.2025.106070_bib163","first-page":"147","article-title":"Methylmercury-l-Cysteine targeting L-type amino acid transporter conjugate cytotoxicity on C6 glioma cells","volume":"32","author":"Wei","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.neuint.2025.106070_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1443789","article-title":"OATP1A2 mediates Abeta(1-42) transport and may be a novel target for the treatment of Alzheimer's disease","volume":"15","author":"Wen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106070_bib165","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3389\/fonc.2019.01268","article-title":"Cationic amino acid Transporter-1-Mediated arginine uptake is essential for chronic lymphocytic leukemia cell proliferation and viability","volume":"9","author":"Werner","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuint.2025.106070_bib166","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/cas.12602","article-title":"Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2","volume":"106","author":"Wongthai","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.neuint.2025.106070_bib167","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1038\/s41467-024-47948-4","article-title":"The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106070_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1251100","article-title":"CD98 heavy chain as a prognostic biomarker and target for cancer treatment","volume":"13","author":"Xia","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuint.2025.106070_bib169","article-title":"Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas","volume":"14","author":"Xu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106070_bib170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-021-00247-4","article-title":"Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter","volume":"7","author":"Yan","year":"2021","journal-title":"Cell Discov"},{"key":"10.1016\/j.neuint.2025.106070_bib171","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41422-022-00642-w","article-title":"The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis","volume":"32","author":"Yan","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.neuint.2025.106070_bib172","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-019-1011-z","article-title":"Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex","volume":"568","author":"Yan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106070_bib173","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/cmdc.201402281","article-title":"Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1)","volume":"9","author":"Ylikangas","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neuint.2025.106070_bib174","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1081\/DMR-120015692","article-title":"Structural biology and function of solute transporters: implications for identifying and designing substrates","volume":"34","author":"Zhang","year":"2002","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.neuint.2025.106070_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.564809","article-title":"Review of the correlation of LAT1 with diseases: mechanism and treatment","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.neuint.2025.106070_bib176","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ibneur.2025.06.014","article-title":"Uptakes of boronophenylalanine in the in vitro and in situ glioblastoma and the potential efficacy of boron neutron capture therapy","volume":"19","author":"Zhang","year":"2025","journal-title":"IBRO Neurosci Rep"},{"key":"10.1016\/j.neuint.2025.106070_bib177","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1007\/s12274-023-5568-3","article-title":"LAT1 targeted brain delivery of temozolomide and sorafenib for effective glioma therapy","volume":"16","author":"Zhang","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.neuint.2025.106070_bib178","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1016\/j.bmcl.2016.09.001","article-title":"LAT1 activity of carboxylic acid bioisosteres: evaluation of hydroxamic acids as substrates","volume":"26","author":"Zur","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:08:12Z","timestamp":1773850092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018625001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":178,"alternative-id":["S0197018625001433"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106070","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crossing the Borders: the amino acid transporter LAT1 (SLC7A5) in the Blood-Brain Barrier","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106070"}}